Loss of Fas-Ligand Expression in Mouse Keratinocytes during UV Carcinogenesis
✍ Scribed by Allal Ouhtit; Alexander Gorny; H. Konrad Muller; Laurie L. Hill; Laurie Owen-Schaub; Honnavara N. Ananthaswamy
- Book ID
- 117022401
- Publisher
- American Society for Investigative Pathology
- Year
- 2000
- Tongue
- English
- Weight
- 518 KB
- Volume
- 157
- Category
- Article
- ISSN
- 0002-9440
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Background and objectives: Fas ligand (fasl) is expressed in many cancers and plays an important role in establishing immunologically privileged environments that allow tumors to escape the host's immune surveillance. we investigate the expression of fasl in human colorectal cancer and colorecta
The monoclonal antibody PA2.26, produced against mouse epidermal keratinocytes transformed with 7,12-dimethylbenz[a]anthracene (DMBA), recognizes a 43- to 47-kDa cell-surface protein that was absent from non-tumorigenic epidermal keratinocytes but present in transformed epidermal cell lines as well
## Abstract Peroxisome proliferator‐activated receptor γ (PPARγ) is a ligand activated transcription factor. There have been suggestions that PPARγ ligands may have utility in preventing tumor development in rodent mammary glands and colon. The recent finding that mice lacking one allele of the __P
## Abstract An anti–tumor‐promoting effect of indomethacin and related nonsteroidal anti‐inflammatory drugs (NSAIDs) as well as the ability of the tumor promoter 12‐__O__‐tetradecanoylphorbol‐13‐acetate (TPA) to increase the level of prostaglandins in murine keratinocytes and mouse epidermis in viv